MedPath

Study of telemedicine in prescribing low dose pills for dysmenorrhea patients

Not Applicable
Conditions
dysmenorrhea
Registration Number
JPRN-UMIN000046405
Lead Sponsor
Yokohama City University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
172
Inclusion Criteria

Not provided

Exclusion Criteria

Common to Both Group 1)Patients who reject to be included this study 2)One or more LEP prescription contraindications are applicable at the start of prescription In-person care Group 1)Patients who start LEP prescription after the telemedicine system introduction

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Probability of abnormal uterine bleeding in 6 months after the start of treatment
Secondary Outcome Measures
NameTimeMethod
Other side effects Continuation rate for treatment Cost burden of patient Treatment effectivity
© Copyright 2025. All Rights Reserved by MedPath